ST Jiaying announced that net profit attributable to shareholders of listed companies for the first half year of 2026 is expected to be -14.1071 million yuan to 1,1542,000 yuan, or 2008.26 million yuan in the same period last year, from profit to loss; net profit after deducting non-recurring profit and loss is -16.6029 million yuan to -13.5842 million yuan, compared to 18.7886 million yuan for the same period last year. The main reason for the loss was a decrease in drug sales due to market adjustments, a decrease in revenue, and an increase in expenses.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.